Skip to content

Lofexidine

NERVOUS SYSTEM

Also known as: (+/-)-Lofexidine, lofexadine, lofexidine HCl, lofexidine hydrochloride

OfpFDA approvedATC N07BC04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Lofexidine is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 2018. DrugCentral lists 7 molecular targets, including Adra2b|Adra2c|Adra2a, ADRA2A and Nisch. Recorded indications include Opioid withdrawal.

  • Approval status: ofp (first approved 2018 by the FDA).
  • Molecular targets: Adra2b|Adra2c|Adra2a, ADRA2A, Nisch and ADRA2B (7 listed in DrugCentral).
  • Indications: Opioid withdrawal.
  • ATC code: N07BC04 (Drugs used in opioid dependence).
  • Molecular formula: C11H12Cl2N2O; molecular weight 259.13 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Opioid withdrawal

Mechanism & targets

Molecular targets (7)

TargetGeneActionActivity
Adrenergic receptor alpha-2Adra2b|Adra2c|Adra2aunknownIC50 8.60
Alpha-2A adrenergic receptorADRA2AagonistKi 8.36
NischarinNischunknownKi 8.25
Alpha-2B adrenergic receptorADRA2BunknownKi 7.17
Alpha-2C adrenergic receptorADRA2CunknownKi 7.16
5-hydroxytryptamine receptor 1AHTR1AunknownKi 6.90
Adrenergic receptor alpha-1Adra1b|Adra1d|Adra1aunknownIC50 6.18

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2018-05-16FDA—US WORLDMEDS LLC

ATC classification

ATC codeTherapeutic hierarchy
N07BC04NERVOUS SYSTEM › OTHER NERVOUS SYSTEM DRUGS › DRUGS USED IN ADDICTIVE DISORDERS › Drugs used in opioid dependence

Pharmacogenomics

Drug-label and guideline annotations from PharmGKB and CPIC.

  • FDA label: CYP2D6 · Actionable PGx

Chemical structure

Molecular formulaC11H12Cl2N2O
Molecular weight259.13 g/mol
CAS number31036-80-3
InChIKeyKSMAGQUYOIHWFS-UHFFFAOYSA-N
PubChem CID30668
CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Lofexidine used for?

DrugCentral lists the following indications for Lofexidine: Opioid withdrawal.

How does Lofexidine work?

Its molecular targets in DrugCentral include Adra2b|Adra2c|Adra2a, ADRA2A (agonist), Nisch and ADRA2B.

When was Lofexidine first approved?

Lofexidine was first approved by the FDA in 2018.

What is the chemical formula of Lofexidine?

Lofexidine has the molecular formula C11H12Cl2N2O and a molecular weight of 259.13 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2018-05-16
AgencyFDA
Targets7
Indications1
FormulaC11H12Cl2N2O
DrugCentral ID1593
Interactive profile